Related Experiment Video
Updated: Aug 15, 2026

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
Published on: February 24, 2014
DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14
Estella A Koppel1, Eirikur Saeland, Désirée J M de Cooker
1Department of Molecular Cell Biology & Immunology, VU University Medical Center Amsterdam, v.d. Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.
Abstract:
The Gram-positive bacterium Streptococcus pneumoniae is the leading causative pathogen in community-acquired pneumonia. The ever-increasing frequency of antibiotic-resistant S. pneumoniae strains severely hampers effective treatments. Thus, a better understanding of the mechanisms involved in the pathogenesis of pneumococcal disease is needed; in particular, of the initial interactions that take place between the host and the bacterium. Recognition of pathogens by dendritic cells is one of the most crucial steps in the induction of an immune response. For efficient pathogen recognition, dendritic cells express various kinds of receptors, including the DC-specific C-type lectin DC-SIGN. Pathogens such as Mycobacterium tuberculosis and HIV target DC-SIGN to escape immunity. Here the in vitro binding of DC-SIGN with S. pneumoniae was investigated. DC-SIGN specifically interacts with S. pneumoniae serotype 3 and 14 in contrast to other serotypes such as 19F. While the data described here suggest that DC-SIGN interacts with S. pneumoniae serotype 14 through a ligand expressed by the capsular polysaccharide, the binding to S. pneumoniae serotype 3 appears to depend on an as yet unidentified ligand. Despite the binding capacity of the capsular polysaccharide of S. pneumoniae 14 to DC-SIGN, no immunomodulatory effects on the dendritic cells were observed. The immunological consequences of the serotype-specific capacity to interact with DC-SIGN should be further explored and might result in new insights in the development of new and more potent vaccines.
Insights
Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) specifically binds Streptococcus pneumoniae serotypes 3 and 14. This interaction, though not immunomodulatory, offers potential for novel vaccine development against pneumococcal disease.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Streptococcus pneumoniae causes community-acquired pneumonia and antibiotic resistance is increasing.
- Understanding host-pathogen interactions is crucial for effective treatment and vaccine development.
- Dendritic cells (DCs) use receptors like DC-SIGN for pathogen recognition, a key step in immune response induction.
Purpose of the Study:
- To investigate the in vitro binding of DC-SIGN with Streptococcus pneumoniae.
- To identify specific S. pneumoniae serotypes that interact with DC-SIGN.
- To explore the potential implications of DC-SIGN interaction in pneumococcal pathogenesis and vaccine strategies.
Main Methods:
- In vitro binding assays were performed to assess the interaction between DC-SIGN and various S. pneumoniae serotypes.
- Ligand identification for DC-SIGN binding was explored, focusing on capsular polysaccharides.
- Immunomodulatory effects of the interaction on dendritic cells were evaluated.
Main Results:
- DC-SIGN specifically binds to S. pneumoniae serotypes 3 and 14, but not to serotype 19F.
- Binding to serotype 14 involves a ligand expressed by the capsular polysaccharide.
- Binding to serotype 3 involves an unidentified ligand.
- No immunomodulatory effects on dendritic cells were observed despite the binding of S. pneumoniae serotype 14 to DC-SIGN.
Conclusions:
- DC-SIGN exhibits serotype-specific binding to Streptococcus pneumoniae.
- The interaction mechanism for serotype 3 binding requires further elucidation.
- While direct immunomodulation was not observed, the serotype-specific interaction with DC-SIGN warrants further investigation for potential vaccine development against pneumococcal infections.
Related Concept Videos
Atypical Pneumonia
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction
Clinical Significance of Antibiotic Resistance

